The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
TWST.COM Logo
  • Home
  • Experts
  • Reports
  • Products
  • News
  • About Us
  • Series
    • General Investing
    • Financial Services
    • Consumer
    • Industry & Services
    • Natural Resources
    • Healthcare
    • Technology
  • Contact Us

Columbia Banking System, Inc.

Related Interviews

Looking to Dividend-Paying Stocks for Good Risk-Adjusted Returns
November 02, 2022
Browne, Thomas E.

Four West Coast Banks Set to Benefit from Rate Hikes
July 31, 2022
Coffey, Timothy N.

Driving Overall Returns Through Stock Selection in the SMID- and Small-Cap Space
February 14, 2020
Wulff, Jason

Strong M&A Prospects in the Pacific Northwest Banking Segment
February 06, 2015

Western Regional Banks Benefit from Improving Economy and Real Estate Values
November 12, 2014

Loan and Deposit Growth in Pacific Northwest Banking
February 24, 2014

Loan Pipelines Building in Pacific Northwest Banks
February 19, 2014

Silicon Valley & West L.A. Banks May Outperform West Coast Peers - Timothy Coffey - FIG Partners
March 05, 2012

Texas Banks Show Strength Despite Regional Headwinds - Brad Milsaps - Sandler O'neill + Partners, L.p.
March 07, 2011

A Close-up On Western Banking Dynamics - Tom Mitchell - Miller Tabak + Co., Llc
March 07, 2011

M.HARDY / R.STECHER / G.SWEENEY - STATE BANK & TRUST
July 17, 2006

Payment & Financial Processors: Brandt Sakakeeny - Deutsche Bank Securities
March 31, 2003

Roundtable Forum: Central Regional Banks
May 21, 2001

Roundtable Forum: Central Regional Banks
May 22, 2000

Cart

Latest News

The Robots from this Company Will Build You a New Spine
Lord Abbett Portfolio Manager Reveals the Process for Picking Winning Innovative Growth Stocks
Fundamental Analysis on Small Cap Stocks: Value Upside Returns

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

Subscribe now!

Sign Up For Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews

Interview with the CEO: Niagen Bioscience Inc. (NASDAQ:NAGE)

Robert Fried

Published March 02, 2026 in Biotechnology and Pharmaceuticals

Companies covered: NAGE

Buy ($25)

Interview with the CEO: Vaxart Inc. (OTCMKTS:VXRT)

Steven Lo

Published March 02, 2026 in Biotechnology and Pharmaceuticals

Companies covered: VXRT

Buy ($25)

Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)

Frank Bedu-Addo

Published March 02, 2026 in Biotechnology and Pharmaceuticals

Companies covered: PDSB

Buy ($25)

Most Popular Reports

Biotechnology and Pharmaceuticals

Published March 02, 2026

Topics covered: Biotechnology and Pharmaceuticals

Buy ($175)

Medical Devices and Life Science Tools

Published February 23, 2026

Topics covered: Medical Devices and Life Science Tools

Buy ($175)

Investing Strategies: Micro, Small and Smid Cap

Published February 05, 2026

Topics covered: Micro, Small and Smid Cap

Buy ($175)

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
GE Aerospace (General Electric Company)
Walmart Inc.
IBM (International Business Machines Corp.)
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Niagen Bioscience Inc. (NASDAQ:NAGE)
Interview with the CEO: Vaxart Inc. (OTCMKTS:VXRT)
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Supply Constraints Translate Into Pricing Power for Eagle Materials
Share Price Pullback Creates Attractive Entry Point for Urban Outfitters
VSE Corp: A Play on Strong Aerospace Aftermarket Demand
ANALYST INTERVIEWS
Argenx Builds Momentum on Strong Execution and Expanding Indications
Omeros Tackles Lethal Transplant Risks with First-in-Class Therapy
Uptick in M&A Among Tailwinds Boosting Biotech Sector
Subscribe Today!
Since 1963
© The Wall Street Transcript 2016, 2026
Terms and Conditions
Privacy Policy
 
 
https://www.twst.com/wp-admin/admin-ajax.php
  • Join now for free!
  • Already a member?

or create an account with a social network.

Join with Facebook
Join with Twitter
Join with Google
Join now! | Forgot password?

or login using a social network


Log in with Facebook
Log in with Twitter
Log in with Google